Botulinum toxin and safety issues in cerebral palsy.
Department of Medical Laboratories, Faculty of Health and Caring Professions, Highest Technological Educational Institute of Athens, Athens, Greece.
Eugenia
E
Yiannakopoulou
D019274:Botulinum Toxins, Type A; D002547:Cerebral Palsy; D006801:Humans; D009128:Muscle Spasticity; D009465:Neuromuscular Agents; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A